Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Jazz Pharmaceuticals PLC (JAZZ.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-04-01158.90-No Rating
2022-06-13141.59194.00Buy
2022-08-03151.66191.00Buy
2023-01-27155.57192.00Buy
2023-03-02144.34194.00Buy
2023-04-10146.27182.00Buy
2023-05-15134.68165.00Buy
2023-08-17137.92169.00Buy
2023-10-11129.99170.00Buy
2023-11-26121.35135.00Neutral
2024-02-29118.90131.00Neutral
2024-04-12110.58121.00Neutral
2024-05-03110.01117.00Neutral
2024-07-02105.09113.00Neutral
2024-08-02113.26121.00Neutral
2024-09-03109.32-No Rating
2024-10-18115.04121.00Neutral
2024-11-18117.59128.00Neutral
2025-02-13136.82145.00Neutral
2025-03-07138.81179.00Buy
2025-04-07106.93166.00Buy
2025-05-07101.44164.00Buy

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking services are being, or have been, provided.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 25% above the MRA for a Buy rating, and at -25% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.